ARTICLE | Company News
Migenix, Cutanea dermatology deal
December 9, 2005 2:14 AM UTC
Migenix (TSX:MGI; MGIFF) granted Cutanea (Philadelphia, Penn.) an exclusive worldwide license to develop and commercialize MX-594AN and its analogs for dermatological indications. The antimicrobial ca...